Your browser doesn't support javascript.
loading
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
Zent, Clive S; Victoria Wang, Xin; Ketterling, Rhett P; Hanson, Curtis A; Libby, Edward N; Barrientos, Jacqueline C; Call, Timothy G; Chang, Julie E; Liu, Jane J; Calvo, Alejandro R; Lazarus, Hillard M; Rowe, Jacob M; Luger, Selina M; Litzow, Mark R; Tallman, Martin S.
Afiliação
  • Zent CS; University of Rochester Medical Center, Rochester, New York (Current Location) Mayo Clinic, Rochester, Minnesota (Former Location).
  • Victoria Wang X; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.
  • Ketterling RP; Mayo Clinic, Rochester, Minnesota.
  • Hanson CA; Mayo Clinic, Rochester, Minnesota.
  • Libby EN; Seattle Cancer Care Alliance, Seattle, Washington (Current Location) University of New Mexico Cancer Center, Albuquerque, NM.
  • Barrientos JC; North Shore-LIJ Health System NCORP, Manhasset, New York.
  • Call TG; Mayo Clinic, Rochester, Minnesota.
  • Chang JE; University of Wisconsin, Madison, Wisconsin.
  • Liu JJ; Illinois CancerCare, Peoria, Illinois.
  • Calvo AR; Kettering Health Network, Kettering, Ohio.
  • Lazarus HM; Case Western Reserve University, Cleveland, Ohio.
  • Rowe JM; Rambam Medical Center, Haifa, Israel.
  • Luger SM; University of Pennsylvania, Philadelphia, Pennsylvania.
  • Litzow MR; Mayo Clinic, Rochester, Minnesota.
  • Tallman MS; Memorial Sloan Kettering Cancer Center, New York, New York (Current Location) Northwestern University School of Medicine, Chicago, Illinois (Former Location).
Am J Hematol ; 91(3): 308-12, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26662208
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Rituximab Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Rituximab Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos